Malaria Research Center, Rourkela, India Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2006
NCT00362050
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now